Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

NCCN Adds Rucaparib to Prostate Cancer Guidelines

The National Comprehensive Cancer Network has updated its Prostate Cancer guidelines to include the PARP inhibitor rucaparib.
Read More >>

Study Links Decline in PSA Screening to Increased Incidence of Advanced Prostate Cancer

Meta-Analysis Finds Adding ADT to EBRT Extends Survival in Localized Prostate Cancer

Rucaparib Prostate Cancer Approval Sets Stage for Further Research

Agarwal Outlines Importance of Olaparib Approval in HRR-Mutant mCRPC

FDA Approves Olaparib for HRR-Mutant mCRPC

View More Stories >>

View Conference Coverage

2020 ESMO Breast Cancer Virtual Meeting

2020 ASCO Virtual Scientific Program

2020 International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2020 AACR Annual Meeting

2020 SGO Annual Meeting

Dr. Klein on Oncotype DX in Predicting Outcomes in African Americans With Prostate Cancer

Dr. Bryce on the FDA Approval of Rucaparib in <em>BRCA</em>-Mutant mCRPC

Dr. Bryce on the FDA Approval of Rucaparib in BRCA-Mutant mCRPC

Dr. Agarwal on the FDA Approval of Olaparib in <em>HRR</em>-Mutant mCRPC

Dr. Agarwal on the FDA Approval of Olaparib in HRR-Mutant mCRPC

Dr. Jain on the Use of Diagnostic Tracers in Prostate Cancer

Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC

Dr. Koo on the Need for Next-Generation Imaging in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Ep. 12: What is Radium 223

Ep. 11: Factors in Selecting Therapy for mCRPC

Ep. 10: How Has the mCRPC Treatment Landscape Changed?

Ep. 9: Neurological AEs and Quality of Life in Treating nmCRPC

Ep. 8: Selecting Optimal AR-Targeted Therapy for nmCRPC

Ep. 7: Current Treatment and Imaging Options for nmCRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Cabazitaxel for the Treatment of mCRPC

Sequencing Therapy in Castrate-Resistant Prostate Cancer

The Use of Taxanes Earlier in Prostate Cancer

Metastatic CSPC: Toxicity Management & Future Treatment

The Role of Enzalutamide in Treating Metastatic CSPC

The Approval of Apalutamide for Metastatic CSPC

The STAMPEDE Trial Long Term Follow-Up Data

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

OncLive Saturday Spotlight: A Morning With NYU Langone Perlmutter Cancer Center

The OncLive Saturday Spotlight webinars feature a panel of top physicians from one of our nation’s leading institutions. This week we have collaborated with NYU Langone Health to highlight important topics facing oncologists today. View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Webinar

Live Broadcast on Metastatic Triple-Negative Breast Cancer